T his multi-site cohort study of general practitioner trainees by Magin et al. 1 examined changes in benzodiazepine prescribing from 2010 through 2015. The investigators examined self-completed case reports of 1161 Australian generalpractitioner registrars (postgraduate learners in outpatient practice-based training) across five diverse training programs over time. After adjusting for registrar-and patient-level characteristics, they found that the within-registrar adjusted odds of reported benzodiazepine prescribing did not change over time, but the within-program adjusted odds of prescribing decreased by 6% per year. Assuming that these trends reflect efforts towards more judicious prescribing, the investigators conclude a reduction in benzodiazepine prescriptions by program-a welcome trend-but a lack of change by registrar suggests opportunities for targeted education.
This study addresses an important gap in our understanding of benzodiazepine prescribing patterns, and its novel focus on primary care trainees shifts our gaze Bupstream^towards early-career clinicians who may be establishing durable prescribing practices. 2 The study's internal validity is strengthened by the registrars' high response rate (96%); generalizability to Australian general practitioner training programs is supported by its large sample across diverse geographic areas. However, postgraduate medical education is a heterogeneous enterprise wherein prescribing often depends on complex interactions between trainees, supervisors, and educational activities, so attributing the observed trends to policy, practice, or education efforts is speculative.
Due to increases in overdose deaths involving benzodiazepines, inappropriate prescribing of benzodiazepines has been termed the Bother prescription drug problem^in the United States, and safer prescribing is needed globally. 3 This study conveys to clinicians, educators, and policymakers that there is room for improvement in postgraduate medical education regarding safe benzodiazepine prescribing. A deeper dive into the higher performing programs in this study may identify successful strategies. Furthermore, ongoing efforts to improve opioid prescribing safety such as through academic detailing 4 or prescription drug monitoring programs 5 -efforts supported by accumulating evidence and resources-may provide models and existing infrastructure for educational programs that promote evidence-based benzodiazepine prescribing. These programs should be evaluated and implemented.
